Source:http://linkedlifedata.com/resource/pubmed/id/16443793
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-1-30
|
pubmed:abstractText |
Common single nucleotide polymorphisms (SNPs) in the ACDC adiponectin encoding gene have been associated with insulin resistance and type 2 diabetes in several populations. Here, we investigate the role of SNPs -11,377C > G, -11,391G > A, +45T > G, and +276G > T in 2,579 French Caucasians (1,229 morbidly obese and 1,350 control subjects). We found an association between severe forms of obesity and -11,377C (odds ratio 1.23, P = 0.001) and +276T (1.19, P = 0.006). Surprisingly, alternative alleles -11,377G and +276G have been previously reported as risk factors for type 2 diabetes. Transmission disequilibrium tests showed a trend in overtransmission (56.7%) of a risk haplotype 1((C))-1((G))-1((T))-2((T)) including -11,377C and +276T in 634 obesity trios (P = 0.097). Family-based analysis in 400 trios from the general population indicated association between obesity haplotype and higher adiponectin levels, suggesting a role of hyperadiponectinemia in weight gain. However, experiments studying the putative roles of SNPs -11,377C > G and +276G > T on ACDC functionality were not conclusive. In contrast, promoter SNP -11,391G > A was associated with higher adiponectin levels in obese children (P = 0.005) and in children from the general population (0.00007). In vitro transcriptional assays showed that -11,391A may increase ACDC activity. In summary, our study suggests that variations at the ACDC/adiponectin gene are associated with risk of severe forms of obesity. However, the mechanisms underlying these possible associations are not fully understood.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0012-1797
|
pubmed:author |
pubmed-author:BalkauBeverleyB,
pubmed-author:Bouatia-NajiNabilaN,
pubmed-author:DinaChristianC,
pubmed-author:FroguelPhilippeP,
pubmed-author:FumeronFrédéricF,
pubmed-author:HeudeBarbaraB,
pubmed-author:JouretBéatriceB,
pubmed-author:LobbensStéphaneS,
pubmed-author:MeyreDavidD,
pubmed-author:SéronKarinK,
pubmed-author:SchererPhilipp EPE,
pubmed-author:WeillJacquesJ
|
pubmed:issnType |
Print
|
pubmed:volume |
55
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
545-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16443793-Adiponectin,
pubmed-meshheading:16443793-Adult,
pubmed-meshheading:16443793-Body Mass Index,
pubmed-meshheading:16443793-Case-Control Studies,
pubmed-meshheading:16443793-Child,
pubmed-meshheading:16443793-Haplotypes,
pubmed-meshheading:16443793-Humans,
pubmed-meshheading:16443793-Insulin Resistance,
pubmed-meshheading:16443793-Obesity,
pubmed-meshheading:16443793-Polymorphism, Single Nucleotide,
pubmed-meshheading:16443793-Risk Factors
|
pubmed:year |
2006
|
pubmed:articleTitle |
ACDC/adiponectin polymorphisms are associated with severe childhood and adult obesity.
|
pubmed:affiliation |
Centre National de la Recherche Scientifique UMR8090, Pasteur Institute of Lille, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|